Study of Serum level of Chrome in Bladder Cancer Patients
ABSTRACT Introduction & Objective: Chrome (Cr) is one of the carcinogen trace elements that its role in cancer induction is documented in many studies. In spite o this, there are limited studies about the relationship between chrome and bladder cancer. So we decided to study the serum concentra...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Yasuj University Of Medical Sciences
2008-12-01
|
| Series: | Armaghane Danesh Bimonthly Journal |
| Subjects: | |
| Online Access: | http://armaghanj.yums.ac.ir/browse.php?a_code=A-10-1-392&slc_lang=en&sid=1 |
| _version_ | 1811201558393651200 |
|---|---|
| author | H Mazdak Mirkheshti A Movahedian F Yazdekhasti E Behzad M Shafian N Ebadati |
| author_facet | H Mazdak Mirkheshti A Movahedian F Yazdekhasti E Behzad M Shafian N Ebadati |
| author_sort | H Mazdak |
| collection | DOAJ |
| description | ABSTRACT
Introduction & Objective: Chrome (Cr) is one of the carcinogen trace elements that its role in cancer induction is documented in many studies. In spite o this, there are limited studies about the relationship between chrome and bladder cancer. So we decided to study the serum concentration of Cr in patients with bladder cancer in comparison with healthy individuals.
Materials & method: During this case control study, 51 patients with bladder cancer and 58 normal subjects, after matching in age, sex and smoking habits with case group, were selected. Blood samples were collected from each cases. Serum level of Cr was measured in all samples by using the Flameless Atomic Absorption Spectrophotometer. Finally data were analyzed, using student t test.
Results: Mean age of participants was 62.74 ± 14.63 years in control group and 58.2 ± 9.8 years in case group. Mean of serum Cr concentration was 128.82 ± 16.99 µg/L in bladder cancer patients and 121.93 ± 16.67 µg/L in control group. The difference in Cr level of serum was significant between two groups (p < 0.05).
Conclusion: Results of this study indicated the high level of Cr in the serum of bladder cancer patients. Performing of some strategies in reduction of environmental contaminations, finding the contaminated sources and modifying them, can be useful, for reduction of serum level of Cr, especially in high risk groups. |
| first_indexed | 2024-04-12T02:23:37Z |
| format | Article |
| id | doaj.art-c0720826b807411dbcd24518ebd9eb2f |
| institution | Directory Open Access Journal |
| issn | 1728-6506 1728-6514 |
| language | fas |
| last_indexed | 2024-04-12T02:23:37Z |
| publishDate | 2008-12-01 |
| publisher | Yasuj University Of Medical Sciences |
| record_format | Article |
| series | Armaghane Danesh Bimonthly Journal |
| spelling | doaj.art-c0720826b807411dbcd24518ebd9eb2f2022-12-22T03:52:04ZfasYasuj University Of Medical SciencesArmaghane Danesh Bimonthly Journal1728-65061728-65142008-12-01133124130Study of Serum level of Chrome in Bladder Cancer PatientsH Mazdak0Mirkheshti1A Movahedian2F Yazdekhasti3E Behzad4M Shafian5N Ebadati6 ABSTRACT Introduction & Objective: Chrome (Cr) is one of the carcinogen trace elements that its role in cancer induction is documented in many studies. In spite o this, there are limited studies about the relationship between chrome and bladder cancer. So we decided to study the serum concentration of Cr in patients with bladder cancer in comparison with healthy individuals. Materials & method: During this case control study, 51 patients with bladder cancer and 58 normal subjects, after matching in age, sex and smoking habits with case group, were selected. Blood samples were collected from each cases. Serum level of Cr was measured in all samples by using the Flameless Atomic Absorption Spectrophotometer. Finally data were analyzed, using student t test. Results: Mean age of participants was 62.74 ± 14.63 years in control group and 58.2 ± 9.8 years in case group. Mean of serum Cr concentration was 128.82 ± 16.99 µg/L in bladder cancer patients and 121.93 ± 16.67 µg/L in control group. The difference in Cr level of serum was significant between two groups (p < 0.05). Conclusion: Results of this study indicated the high level of Cr in the serum of bladder cancer patients. Performing of some strategies in reduction of environmental contaminations, finding the contaminated sources and modifying them, can be useful, for reduction of serum level of Cr, especially in high risk groups.http://armaghanj.yums.ac.ir/browse.php?a_code=A-10-1-392&slc_lang=en&sid=1KEYWORDS:Bladder CancerChrometrace element |
| spellingShingle | H Mazdak Mirkheshti A Movahedian F Yazdekhasti E Behzad M Shafian N Ebadati Study of Serum level of Chrome in Bladder Cancer Patients Armaghane Danesh Bimonthly Journal KEYWORDS:Bladder Cancer Chrome trace element |
| title | Study of Serum level of Chrome in Bladder Cancer Patients |
| title_full | Study of Serum level of Chrome in Bladder Cancer Patients |
| title_fullStr | Study of Serum level of Chrome in Bladder Cancer Patients |
| title_full_unstemmed | Study of Serum level of Chrome in Bladder Cancer Patients |
| title_short | Study of Serum level of Chrome in Bladder Cancer Patients |
| title_sort | study of serum level of chrome in bladder cancer patients |
| topic | KEYWORDS:Bladder Cancer Chrome trace element |
| url | http://armaghanj.yums.ac.ir/browse.php?a_code=A-10-1-392&slc_lang=en&sid=1 |
| work_keys_str_mv | AT hmazdak studyofserumlevelofchromeinbladdercancerpatients AT mirkheshti studyofserumlevelofchromeinbladdercancerpatients AT amovahedian studyofserumlevelofchromeinbladdercancerpatients AT fyazdekhasti studyofserumlevelofchromeinbladdercancerpatients AT ebehzad studyofserumlevelofchromeinbladdercancerpatients AT mshafian studyofserumlevelofchromeinbladdercancerpatients AT nebadati studyofserumlevelofchromeinbladdercancerpatients |